Serological response following vaccination with BNT162b2 mRNA in patients with chronic lymphocytic leukemia.

da Cunha-Bang, Caspar; Kirkby, Nikolai S; Friis-Hansen, Lennart; Niemann, Carsten U

da Cunha-Bang, Caspar; Kirkby, Nikolai S; Friis-Hansen, Lennart; Niemann, Carsten U.

da Cunha-Bang C; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
Kirkby NS; Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Friis-Hansen L; Department of Clinical Biochemistry, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
Niemann CU; Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.

Leuk Lymphoma ; 63(2): 503-505, 2022 02.

Article in English | MEDLINE | ID: covidwho-1499106

Subject(s)

Leukemia, Lymphocytic, Chronic, B-Cell; Antibodies, Viral; Humans; Leukemia, Lymphocytic, Chronic, B-Cell/genetics; RNA, Messenger/genetics; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell Topics: Vaccines Limits: Humans Language: English Journal: Leuk Lymphoma Journal subject: Hematology / Neoplasms Year: 2022 Document Type: Article Affiliation country: 10428194.2021.1973673

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google